AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05294094 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: teaching format as usual
Description: The teaching format as usual represents the usual teaching of clinical diagnostic knowledge and the ability to conduct structured clinical interviews. Also in this intervention students also have the opportunity to discuss the course content with a teacher, practice their interviewing skills with other students and conduct a structured interview with an actor simulating a patient.
Study NCT05943522 — intervention group
Intervention type: OTHER
Intervention: Asciminib
Description: There is no treatment allocation. Asciminib will be prescribed by the physician as per locally approved label. No drug will be dispensed from Novartis
Study NCT05947955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rhu-pGSN
Description: Intravenous administration based on actual body weight
Study NCT05947955 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: intravenous administration in the same volume as the active therapy
Study NCT05119712 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Terbinafine Tablets
Description: 500mg oral terbinafine or placebo daily
Study NCT05119712 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Testing
Description: Laboratory testing at screening, baseline, week 8, 16, 24 and 32.
Study NCT05119712 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Testing
Description: Subjects with the potential to become pregnant will have a baseline urine pregnancy test prior to starting study drug.
Study NCT05493020 — intervention group
Intervention type: OTHER
Intervention: Questionnaires set
Description: At baseline, the children's demographics, disease-related data, characteristics of Mukbangwatching behavior, appetite, nutritional status, and quality of life data were collected. From the first day of radiotherapy or chemotherapy, 3 meals a day for 5 consecutive days were followed to track the children's appetite status and the characteristics of Mukbangwatching behavior. Their nutritional status and quality of life were tracked at the end of treatment or when they were discharged from the hospital.
Study NCT06344078 — intervention group
Intervention type: PROCEDURE
Intervention: sigmoid resection and anastomosis / stoma
Description: intestinal resection and recostruction or creation of stoma
Study NCT01675986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydroxyzine
Description: 75 mg
Study NCT01675986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: 150 mg
Study NCT01675986 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactose
Description: 4 g
Study NCT04880577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]
Description: The study is designed to add on TAF to anti-CD20 therapies
Study NCT04880577 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo arm
Study NCT05273827 — intervention group
Intervention type: DRUG
Intervention: neoadjuvant immunotherapy
Description: Anti-PD-1 antibody was added to the conventional neoadjuvant chemotherapy.
Study NCT05273827 — intervention group
Intervention type: DRUG
Intervention: Neoadjuvant chemotherapy
Description: Cis-platinum combined with paclitaxel or pemetrexed
Study NCT06046261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACP board game for life
Description: The research subjects will be assigned to the experimental group or the control group according to their wishes. Those who are willing to participate the ACP board game will be assigned to the experimental group. The intervention time for each board game is around 2 hours. There are 60 cards in this ACP board game; the focus of the game is to know the participants' thoughts on the card options. Questionnaires need to be filled in before and after intervention.
Study NCT04631029 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV
Study NCT04631029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT04631029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entinostat
Description: Given PO
Study NCT04631029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV
Study NCT05639855 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Health Literacy Programme
Description: Mental Health Literacy Program. This program is part of the training of third-year students of the occupational therapy degree at the University of A Coruña. We will follow a mixed method following a sequential explanatory design. The quantitative part corresponds to a quasi-experimental study, where a comparison will be made between the phase before and after the students take the program. The qualitative part will comprise a phenomenological study to collect the knowledge acquired by the students after taking the program.
Study NCT04623983 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bonding tray
Description: Orthodontic bonding tray
Study NCT04711707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community navigator
Description: All patients who consent to participate in the study will complete a pediatric social history tool to identify social needs. The intervention group will receive support through a community navigator to guide and understand appropriate services for their specific needs. This arm will receive guidance and bimonthly check-ins.
Study NCT04711707 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Self-Navigation
Description: The control group will receive an electronic or paper copy of community resources that address the identified social needs.
Study NCT06063109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THP-00101 (Dapagliflozin) 10mg
Description: Dapagliflozin 10mg Tablet / 5 days in period 1 and period 2 will be given to Arm A Dapagliflozin 10mg Tablet / 5 days in period 2 will be given to Arm B
Study NCT06063109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THP-00102 (Telmisartan) 80mg
Description: Telmisartan 80mg Tablet / 5 days in period 1 and period 2 will be given to Arm B Telmisartan 80mg Tablet / 5 days in period 2 will be given to Arm A
Study NCT05929690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-acupuncture
Description: Participants be taught to safely apply acupuncture bilaterally using traditional acupuncture needles to the acupuncture point Stomach 36. If deemed to be clinically appropriate by the acupuncturists, and if patients are willing and able, they will also be taught how to safely needle the acupuncture points Spleen 6 and/or Liver 3 (maximum of six points in total).
Study NCT05493319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: Both groups will train three times a week, twice synchronously online and once asynchronously, considering a standardized exercise guideline. In all intervention sessions, conventional exercises will be guided by the standardized exercise guideline previously developed by the study team, for 4 weeks. Hypopresive, strength and resistance exercises group will receive static hypopressive exercise in supine position, with variant of arms in flexion, abduction and extension, consisting of 3 exercises at the end of the intervention with strength and resistance exercises.
Study NCT05493319 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercises
Description: Both groups will train three times a week, twice synchronously online and once asynchronously, considering a standardized exercise guideline. In all intervention sessions, conventional exercises will be guided by the standardized exercise guideline previously developed by the study team, for 4 weeks. Hypopresive, strength and resistance exercises group will receive static hypopressive exercise in supine position, with variant of arms in flexion, abduction and extension, consisting of 3 exercises at the end of the intervention with strength and resistance exercises.
Study NCT05702528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Apollo Neuro
Description: The group will complete daily use of the Apollo Neuro, a wrist-worn consumer wellness device
Study NCT05001347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TJ004309
Description: Antibody to CD73
Study NCT05388539 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Theta Burst Stimulation
Description: 3 TBS sessions per day, with an offer of 1200 pulses per session and a 30-minute interval between sessions. This protocol will be applied to patients for 15 days, totaling 45 stimulation sessions. The stimulations will be directed to the left dorsolateral prefrontal cortex (F3 obtained by the Beam method) and will be performed in a Magventure MagPro R30 device.The stimulation will be delivered at 100% of the motor threshold and will last for 6 minutes.
Study NCT05388539 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Stimulation
Description: The placebo will consist of a sham stimulation activity. A noise generator, which makes the same noise as active stimulation, and a surface electrode placed over the patient's eyebrow, mimicking the tactile sensory effects of TBS. It will also occur three times a day, with a duration of 6 minutes. The interval time between procedures will be of 30 minutes. It will take place for the same 15 weekdays, totalizing 45 sham stimulations.
Study NCT05469971 — intervention group
Intervention type: GENETIC
Intervention: KIR genotyping
Description: DNA extraction and KIR genotyping by KIR SSO Genotyping Test (One Lambda, Thermo Fisher, Monza, Italy).
Study NCT06149234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fruit leather on the tongue
Description: The patient holds a fruit leather strip on the tongue while being exposed.
Study NCT06149234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Chewing gum strip
Description: The patient holds a banana-tasting gum strip on the tongue while being exposed.
Study NCT06149234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Celluloid matrix group
Description: The patient holds a celluloid matrix stirp gum strip on the tongue while being exposed.
Study NCT06275503 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Screening invitation mode
Description: Cluster randomized study to compare mode of invitation
Study NCT05386329 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindset: Therapist-guided smartphone-delivered CBT
Description: All participants will receive the app-delivered CBT, including modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., activity scheduling), and mindfulness. Therapists will also conduct brief weekly virtual appointments with participants.
Study NCT05945953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Incentive spirometer as visual feedback
Description: Incentive spirometer as deep breathing then UE movement in sitting: Frequency: 2 sets of 10x Intensity: Up to tolerance (hold breath for 2-4 secs). Time: Twice a week Type: Deep breathing exercise UE movement: Gentle ROMs (5 reps)~along with conventional Treatment; Passive stretching of spastic muscles, Strengthening of weak muscles using manual resistance, Diaphragmatic Breathing, Resisted Diaphragmatic Breathing (placing 5Ib sandbag on abdomen).
Study NCT05945953 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diaphragmatic breathing exercise (Mirror mediated therapy)
Description: Diaphragmatic breathing exercise (Mirror mediated therapy): In front of mirror deep breathing with UE movement in sitting: Frequency: 1 cycle of 10x Intensity: Up to tolerance. Time: 3 times per week. Type: Deep breathing exercise. UE movement: Gentle ROMs (5 reps).~along with conventional Treatment; Passive stretching of spastic muscles, Strengthening of weak muscles using manual resistance, Diaphragmatic Breathing, Resisted Diaphragmatic Breathing (placing 5Ib sandbag on abdomen).
Study NCT05648435 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lithium measures
Description: Measurements of lithium levels in blood and urine
Study NCT06276803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: LINFU®
Description: Patients will undergo low intensity non-focused ultrasound excitation of the pancreas for a total of 15 minutes using a GE LOGIQ10 or other FDA approved, FDA cleared or FDA exempt ultrasound insonation. A contrast agent will be administered IV during the ultrasound insonation and the patient will also receive a dose of secretin. The pancreatic juice will then be collected for a total of 15 minutes.
Study NCT06302218 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.2% Injectable Solution
Description: iPACK block + Adductor Canal Block
Study NCT06302218 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.2% Injectable Solution
Description: Erector Spinae Plane Block
Study NCT06302218 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: control group
Description: only spinal anesthesia
Study NCT04901299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NERATINIB
Description: Neratinib will be given orally once daily on a continuous daily dosing schedule i.e., no break in dosing. Dosage per protocol
Study NCT04901299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FULVESTRANT
Description: Fulvestrant will be given via injection every two weeks for the first 28-day cycle and every four weeks thereafter, dosage per protocol
Study NCT06023979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Full weight bearing
Description: Full weight bearing monitored with a bio-feedback insole
Study NCT06023979 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Partial weight bearing
Description: Partial weight bearing monitored with a bio-feedback insole
Study NCT05066256 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Left ventricular diastolic function
Description: Transthoracic echocardiography Mitral E/e'
Study NCT05066256 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Inferior vena cava variation
Description: Inferior vena cava variation from ultrasound
Study NCT06255457 — intervention group
Intervention type: PROCEDURE
Intervention: Mitral valve surgery
Description: Mitral valve repair or replacement of mitral regurgitation
Study NCT05354986 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothpaste with hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP)
Description: Subgingival instrumentation will be performed in two sessions, with a maximum interval of one week, with hand and automatic devices, under local anaesthesia. Full-mouth dental polishing (air-polishing) will be performed immediately after the second session, to eliminate any dental staining.~Experimental anti-staining toothpaste formulation (Dentaid, Barcelona, Spain) includes hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP), within its ingredients. Participants will use the test or control toothpaste three times daily with a manual toothbrush followed by the use, twice daily, of a 0.12% chlorhexidine, commercially available, mouth rinse.
Study NCT05354986 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Toothpaste without hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP)
Description: Subgingival instrumentation will be performed in two sessions, with a maximum interval of one week, with hand and automatic devices, under local anaesthesia. Full-mouth dental polishing (air-polishing) will be performed immediately after the second session, to eliminate any dental staining.~Experimental anti-staining toothpaste formulation without tripolyphosphate and polyvinylpyrrolidone (PVP), within its ingredients. Participants will use the test or control toothpaste three times daily with a manual toothbrush followed by the use, twice daily, of a 0.12% chlorhexidine, commercially available, mouth rinse.
Study NCT05662423 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Expressive Writing about Childbirth
Description: Participants will write repeatedly about their deepest emotions and thoughts related to their recent childbirth, focusing on the most stressful experiences.
Study NCT05662423 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Neutral Writing
Description: Participants will write repeatedly about neutral daily events/tasks not related to childbirth.
Study NCT06093139 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic capsule
Description: probiotic capsule (composition same as described above - L. acidophilus FB0012, L. plantarum FB0015, and L. rhamnosus FB0047 encapsulated in acid-resistant capsules
Study NCT06093139 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo consisted of the same capsules filled with potato starch
Study NCT05558878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ambroxol Oral Product
Description: Drug: Ambroxol (75 mg capsule)~Ambroxol is a mucolytic and expectorant drug. Ambroxol has been approved as lozenges for topical analgesia of sore throat in pharyngitis owing to its local anesthetic properties. Anti-inflammatory properties of ambroxol were confirmed by numerous studies. Ambroxol affect neuronal transduction by blocking (TTX)-resistant Na+ channels (Nav1.8) in small (pain-sensing) dorsal root ganglion neurons more potently than TTX-sensitive channels.
Study NCT05616936 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: injectable platelet rich fibrin
Description: injectable platelet rich fibrin
Study NCT05304507 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-PROTECT model
Description: The I-PROTECT model is based on existing research and knowledge of experts in sport medicine, sport psychology and implementation science, with the involvement of end-users throughout the process. The interdisciplinary intervention includes exercises based on physical and psychological principles of effective injury prevention training, specifically tailored for youth handball players, and support for developing a continuous implementation strategy. The intervention is delivered through a mobile application specifically developed for the I-PROTECT project (the I-PROTECT GO), including coach, player, club administrator, and caregiver modules. Coaches are introduced to the intervention in a workshop, and they will conduct the exercises with their teams during handball practice. Players will have support for conducting exercises on their own, and club administrators for developing an implementation strategy. Caregivers will have tailored information about injury prevention training.
Study NCT05304507 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Youth coaches in the control group club will be asked to use injury prevention training available in the coach education material (Ready for handball), i.e., current practice in Sweden.
Study NCT06149858 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hernioplasty
Description: ventral hernia repair with mesh
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Floss Band
Description: A floss band will be applied to the ankle joint and the participant will practice various weight-bearing active ankle motions simultaneously.
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Floss Band
Description: A floss band will be applied to the ankle joint and the participant will practice various weight-bearing active ankle motions simultaneously.
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mulligan Mobilization
Description: Mulligan mobilization will be applied to the ankle joint and the participant will practice various weight-bearing active ankle motions simultaneously.
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization
Description: Mulligan mobilization will be applied to the ankle joint and the participant will practice various weight-bearing active ankle motions simultaneously.
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Participants will practice various weight-bearing active ankle motions simultaneously.
Study NCT06392880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Participants will practice various weight-bearing active ankle motions simultaneously.
Study NCT05110677 — intervention group
Intervention type: DEVICE
Intervention: Multispectral Optoacoustic Tomography (MSOT)
Description: non-invasive transcutaneous imaging of subcellular muscle components
Study NCT06438172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HCP1803-3
Description: Take it once daily for 8 weeks orally.
Study NCT06438172 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RLD2001-1
Description: Take it once daily for 8 weeks orally.
Study NCT06438172 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HPP2003-3
Description: Placebo drug. Take it once daily for 8 weeks orally.
Study NCT06438172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HPP2002-1
Description: Placebo drug. Take it once daily for 8 weeks orally.
Study NCT05946408 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised antenatal exercises
Description: Supervised antenatal exercises along with education twice a week. Protocol consists of warm up (10 min), Aerobic training (20 mins, 60-75% of max. HR), Strength training (25 minutes), followed by a cool down of 15 minutes.~The Interventions to be provided for a period of 12 weeks.
Study NCT05946408 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Antenatal Education
Description: Antenatal education at 12th week of pregnancy. Which consists of education on Posture in pregnancy, Role of pelvic floor muscles, Labor and breathing and relaxation techniques.